drugset / Trial / NCT00760045
Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time
RandomizedCrossoverTriple-blindBasic science
Summary
The purpose of the study is to observe lacrimal fluid condition (tear film break-up time) chronologically after a single dose of AL-43546 ophthalmic products（0.15%, 0.25% and vehicle）and 0.1% sodium hyaluronate ophthalmic solution and compare lacrimal fluid retention time between them.
Timeline
- Start
- 2008-08
- Primary completion
- 2008-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxypropyl Guar Galactomannan | Unknown | 0.15 % | Other |
| Subject | Hydroxypropyl Guar Galactomannan | Unknown | 0.25 % | Other |
| Comparator | Sodium Hyaluronate | Other / unclassified | 0.1 % | Other |